The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis

Khanna C, Lindblad-Toh K, Vail D et al (2006) The dog as a cancer model. Nat Biotechnol 24:1065–1066 Favier RP, Spee B, Penning LC et al (2011) Copper-induced hepatitis: the COMMD1 deficient dog as a translational animal model for human chronic hepatitis. Vet Q 31:49–60 Debenham SL, Hart EA, Ashurst JL et al (2005) Genomic sequence of the class II region of the canine MHC: comparison with the MHC of other mammalian species. Genomics 85:48–59 Wilbe M, Jokinen P, Truve K et al (2010) Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex. Nat Genet 42:250–254 Lindblad-Toh K, Wade CM, Mikkelsen TS et al (2005) Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438:803–819 Rao NA, van Wolferen ME, van den Ham R et al (2008) cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype. Anim Genet 39:333–345 Sawhney R, Visvanathan K (2011) Polymorphisms of toll-like receptors and their pathways in viral hepatitis. Antivir Ther 16:443–458 Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354:54–66 Watson PJ (2004) Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment. Vet J 167:228–241 Poldervaart JH, Favier RP, Penning LC et al (2009) Primary hepatitis in dogs: a retrospective review (2002–2006). J Vet Intern Med 23:72–80 Bexfield NH, Andres-Abdo C, Scase TJ et al (2011) Chronic hepatitis in the English springer spaniel: clinical presentation, histological description and outcome. Vet Rec 169:415 Shih JL, Keating JH, Freeman LM et al (2007) Chronic hepatitis in Labrador Retrievers: clinical presentation and prognostic factors. J Vet Intern Med 21:33–39 Crawford MA, Schall WD, Jensen RK et al (1985) Chronic active hepatitis in 26 Doberman pinschers. J Am Vet Med Assoc 187:1343–1350 Bishop L, Strandberg JD, Adams RJ et al (1979) Chronic active hepatitis in dogs associated with leptospires. Am J Vet Res 40:839–844 Jarrett WF, O’Neil BW (1985) A new transmissible agent causing acute hepatitis, chronic hepatitis and cirrhosis in dogs. Vet Rec 116:629–635 Rakich PM, Prasse KW, Lukert PD et al (1986) Immunohistochemical detection of canine adenovirus in paraffin sections of liver. Vet Pathol 23:478–484 Chouinard L, Martineau D, Forget C et al (1998) Use of polymerase chain reaction and immunohistochemistry for detection of canine adenovirus type 1 in formalin-fixed, paraffin-embedded liver of dogs with chronic hepatitis or cirrhosis. J Vet Diagn Invest 10:320–325 Kapoor A, Simmonds P, Gerold G et al (2011) Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci USA 108:11608–11613 Leifer CE, Page RL, Matus RE et al (1987) Proliferative glomerulonephritis and chronic active hepatitis with cirrhosis associated with Corynebacterium parvum immunotherapy in a dog. J Am Vet Med Assoc 190:78–80 Mylonakis ME, Kritsepi-Konstantinou M, Dumler JS et al (2010) Severe hepatitis associated with acute Ehrlichia canis infection in a dog. J Vet Intern Med 24:633–638 Rallis T, Day MJ, Saridomichelakis MN et al (2005) Chronic hepatitis associated with canine leishmaniosis (Leishmania infantum): a clinicopathological study of 26 cases. J Comp Pathol 132:145–152 Kearns S (2009) Infectious hepatopathies in dogs and cats. Top Companion Anim Med 24:189–198 Spee B, Arends B, van den Ingh TS et al (2006) Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs. J Vet Intern Med 20:1085–1092 Sevelius E, Andersson M, Jonsson L (1994) Hepatic accumulation of alpha-1-antitrypsin in chronic liver disease in the dog. J Comp Pathol 111:401–412 Rogers WA, Ruebner BH (1977) A retrospective study of probable glucocorticoid-induced hepatopathy in dogs. J Am Vet Med Assoc 170:603–606 Bunch SE, Castleman WL, Hornbuckle WE et al (1982) Hepatic cirrhosis associated with long-term anticonvulsant drug therapy in dogs. J Am Vet Med Assoc 181:357–362 Gocke DJ, Morris TQ, Bradley SE (1970) Chronic hepatitis in the dog: the role of immune factors. J Am Vet Med Assoc 156:1700–1705 Mandigers PJ, van den Ingh TS, Spee B et al (2004) Chronic hepatitis in Doberman pinschers. A review. Vet Q 26:98–106 Sterczer A, Gaal T, Perge E et al (2001) Chronic hepatitis in the dog—a review. Vet Q 23:148–152 Strombeck DR, Gribble D (1978) Chronic active hepatitis in the dog. J Am Vet Med Assoc 173:380–386 Thornburg LP (1998) Histomorphological and immunohistochemical studies of chronic active hepatitis in Doberman Pinschers. Vet Pathol 35:380–385 Boisclair J, Dore M, Beauchamp G et al (2001) Characterization of the inflammatory infiltrate in canine chronic hepatitis. Vet Pathol 38:628–635 Fuentealba C, Guest S, Haywood S et al (1997) Chronic hepatitis: a retrospective study in 34 dogs. Can Vet J 38:365–373 Speeti M, Stahls A, Meri S et al (2003) Upregulation of major histocompatibility complex class II antigens in hepatocytes in Doberman hepatitis. Vet Immunol Immunopathol 96:1–12 Marcellin P (2009) Hepatitis B and hepatitis C in 2009. Liver Int 29(Suppl 1):1–8 Zignego AL, Piluso A, Giannini C (2008) HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation. Autoimmun Rev 8:107–111 Lai M, Liaw YF (2010) Chronic hepatitis B: past, present, and future. Clin Liver Dis 14:531–546 Shi YH, Shi CH (2009) Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15:3099–3105 Guidotti LG, Chisari FV (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1:23–61 Bogdanos DP, Mieli-Vergani G, Vergani D (2004) Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection. Clin Infect Dis 38:1505 (author reply 1505–1506) Bogdanos DP, Mieli-Vergani G, Vergani D (2005) Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? Clin Infect Dis 40:508–510 Obermayer-Straub P, Manns MP (2001) Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmun 16:275–285 Bogdanos DP, Muratori L, Bianchi FB et al (2000) Hepatitis C virus and autoimmunity. Hepatology 31:1380 Gregorio GV, Choudhuri K, Ma Y et al (2003) Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol 133:404–413 Bogdanos DP, Mieli-Vergani G, Vergani D (2009) Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 29:241–253 Bogdanos DP, Dalekos GN (2008) Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s. Curr Med Chem 15:2285–2292 Alvarez F, Berg PA, Bianchi FB et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938 Hennes EM, Zeniya M, Czaja AJ et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176 Bogdanos DP, Invernizzi P, Mackay IR et al (2008) Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 14:3374–3387 Bogdanos DP, Mieli-Vergani G, Vergani D (2001) Liver-kidney microsomal antibody-positive autoimmune hepatitis in the United States. Am J Gastroenterol 96:3447–3448 Smith BE, Tompkins MB, Breitschwerdt EB (2004) Antinuclear antibodies can be detected in dog sera reactive to Bartonella vinsonii subsp. berkhoffii, Ehrlichia canis, or Leishmania infantum antigens. J Vet Intern Med 18:47–51 Kelly PJ, Carter SD, Bobade PA et al (1994) Absence of antinuclear antibodies in dogs infected with Ehrlichia canis. Vet Rec 134:382 Harrus S, Day MJ, Waner T et al (2001) Presence of immune-complexes, and absence of antinuclear antibodies, in sera of dogs naturally and experimentally infected with Ehrlichia canis. Vet Microbiol 83:343–349 Gershwin LJ (2005) Antinuclear antibodies in domestic animals. Ann N Y Acad Sci 1050:364–370 Saunders GK, Monroe WE (2006) Systemic granulomatous disease and sialometaplasia in a dog with Bartonella infection. Vet Pathol 43:391–392 Lenoir AA, Storch GA, DeSchryver-Kecskemeti K et al (1988) Granulomatous hepatitis associated with cat scratch disease. Lancet 1:1132–1136 Hopf U, Meyer zum Buschenfelde KH, Arnold W (1976) Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med 294:578–582 Manns M, Meyer zum Buschenfelde KH, Hutteroth TH et al (1980) Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay. Clin Exp Immunol 42:263–272 Meliconi R, Stancari MV, Garagnani M et al (1983) Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology. Clin Exp Immunol 51:565–571 Manns M, Meyer zum Buschenfelde KH, Hess G (1980) Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity. Gut 21:955–961 Weiss DJ, Armstrong PJ, Mruthyunjaya A (1995) Anti-liver membrane protein antibodies in dogs with chronic hepatitis. J Vet Intern Med 9:267–271 Bogdanos DP, Bianchi I, Ma Y et al (2004) Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin Chem 50:682–683 (author reply 683–684) Rigopoulou EI, Roggenbuck D, Smyk DS et al (2012) Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev Bogdanos DP, Choudhuri K, Vergani D (2001) Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 21:225–232 Bogdanos DP, Lenzi M, Okamoto M et al (2004) Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol 17:83–92 Bogdanos DP, McFarlane IG (2003) Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. J Hepatol 39:860–863 Bogdanos DP, Mieli-Vergani G, Vergani D (2000) Virus, liver and autoimmunity. Dig Liver Dis 32:440–446 Bogdanos DP, Rigopoulou EI (2006) Self-mimicking autoimmune domains of hepatitis C virus core antigen. Vaccine 24:6173–6174 Bogdanos DP, Rigopoulou EI (2007) Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes. Diabetes Res Clin Pract 77:155–156 Bogdanos DP, Smith H, Ma Y et al (2005) A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol 12:217–224 Muratori L, Bogdanos DP, Muratori P et al (2005) Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol 3:595–603 Kerkar N, Choudhuri K, Ma Y et al (2003) Cytochrome P4502D6(193–212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 170:1481–1489 Longhi MS, Hussain MJ, Bogdanos DP et al (2007) Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 46:472–484 Longhi MS, Ma Y, Bogdanos DP et al (2004) Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41:31–37 Longhi MS, Ma Y, Mitry RR et al (2005) Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 25:63–71 Ma Y, Bogdanos DP, Hussain MJ et al (2006) Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 130:868–882 Bogdanos DP, Smyk DS, Rigopoulou EI et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38:J156–J169 Vergani D, Longhi MS, Bogdanos DP et al (2009) Autoimmune hepatitis. Semin Immunopathol 31:421–435 Bexfield NH, Buxton RJ, Vicek TJ et al (2012) Breed, age and gender distribution of dogs with chronic hepatitis in the United Kingdom. Vet J 193:124–128